About Ivan Liachko
Form D filings for Phase Genomics from 2017 to 2023 list Ivan Liachko as chief executive officer and director.
Ivan Liachko first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name Ivan Liachko in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ivan Liachko works with at each company, as listed on that company's latest Form D.
Phase Genomics, Inc. · Form D, Mar 21, 2023
SS
Shawn Sullivan
Executive officer and promoter
KY
Kayla Young
Executive officer